Return
Association of Glucose-Lowering Agents with Readmission Risk in Patients with Rheumatoid Arthritis and Comorbid Type 2 Diabetes Mellitus
J
M
J
X
H
R
DOI:10.1016/j.phrs.2026.108370.png)
Abstract
En 中文
• A 10-year cohort used IPTW and shared Gamma frailty models • Metformin is associated with a 44% reduction in recurrent unplanned readmission risk • Insulin also shows a significant association with lower unplanned readmission risk • Metformin’s inverse association is pronounced in patients receiving glucocorticoids
Keywords:
Rheumatoid arthritis
Type 2 diabetes mellitus
Glucose-lowering agents
Shared Gamma frailty model
Recurrent event data
Public health
Journal
IF:
10.5
Papers:
8.7K
Citations:
3.6W
